TD Asset Management Inc Purchases 113,293 Shares of Colgate-Palmolive Company $CL

TD Asset Management Inc raised its position in Colgate-Palmolive Company (NYSE:CLFree Report) by 3.3% during the 2nd quarter, HoldingsChannel reports. The fund owned 3,538,404 shares of the company’s stock after buying an additional 113,293 shares during the quarter. TD Asset Management Inc’s holdings in Colgate-Palmolive were worth $321,641,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of CL. Brighton Jones LLC lifted its stake in Colgate-Palmolive by 4.4% in the 4th quarter. Brighton Jones LLC now owns 10,578 shares of the company’s stock valued at $962,000 after acquiring an additional 450 shares in the last quarter. GAMMA Investing LLC lifted its stake in Colgate-Palmolive by 14.2% in the 1st quarter. GAMMA Investing LLC now owns 11,797 shares of the company’s stock valued at $1,105,000 after acquiring an additional 1,468 shares in the last quarter. NorthCrest Asset Manangement LLC raised its stake in shares of Colgate-Palmolive by 65.8% during the 1st quarter. NorthCrest Asset Manangement LLC now owns 3,329 shares of the company’s stock worth $312,000 after purchasing an additional 1,321 shares in the last quarter. Elevation Point Wealth Partners LLC raised its stake in shares of Colgate-Palmolive by 8.3% during the 1st quarter. Elevation Point Wealth Partners LLC now owns 3,572 shares of the company’s stock worth $335,000 after purchasing an additional 273 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its stake in shares of Colgate-Palmolive by 23.8% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 329,826 shares of the company’s stock worth $30,905,000 after purchasing an additional 63,419 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

CL has been the topic of a number of analyst reports. Citigroup dropped their price objective on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, August 4th. The Goldman Sachs Group dropped their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, October 2nd. Bank of America dropped their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. UBS Group dropped their price objective on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Finally, Morgan Stanley dropped their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Eight analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.21.

Get Our Latest Stock Report on CL

Colgate-Palmolive Stock Down 1.2%

CL stock opened at $76.99 on Tuesday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The firm has a market capitalization of $62.22 billion, a PE ratio of 21.63, a PEG ratio of 4.29 and a beta of 0.34. Colgate-Palmolive Company has a 1-year low of $76.68 and a 1-year high of $102.61. The business’s 50 day simple moving average is $82.44 and its 200 day simple moving average is $87.73.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm’s revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.91 EPS. As a group, research analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be issued a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 58.43%.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.